Clinical Trial: New Treatment of Common Wart

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543926) titled 'New Treatment of Common Wart' on April 01.

Brief Summary: this study aims to compare the efficacy and safety of platelet rich fibrin injection versus intralesional vitamin D injection in the treatmentof common warts. PRF, as an autologous biological material , may enhance tissue regeneration and immune response.

Study Start Date: April 06

Study Type: INTERVENTIONAL

Condition: Common Warts (Verruca Vulgaris)

Intervention: BIOLOGICAL: PRF group

intralesional PRF injection in common warts

DRUG: Vitamin D

intralesional vitamin D injection in common wart

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sohag University

Inform...